Synergene Active Ingredients Private Limited, incorporated in 2006, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs), Intermediates and Specialty Chemicals. The therapeutic segments of focus include Anti fungal, Anti depressant, Anti migraine, Anti hypertensive, Anti glaucoma, Anti histamine, Anti biotic, Analgesic, Premature Ejaculation and Nootropic. Synergene is one of the leading manufacturers in Asia for Terbinafine Hydrochloride, Fluconazole, Voriconazole and Escitalopram Oxalate. It has CEP for the products, Terbinafine Hydrochloride and Fluconazole. Synergene has been granted process patents for Luliconazole, Dapoxetine Hydrochloride and Escitalopram Oxalate. Synergene manufacturing facilities are cGMP compliant meeting applicable regulatory standards in terms of Infrastructure and Quality Management Systems. The company has three manufacturing facilities, one in Hyderabad and the other two in Vishakhapatnam. It acquired Jaahnavee Life Sciences Pvt. Ltd. at Visakhapatnam in 2018. Synergene Unit II , Visakhapatnam has been inspected and approved by the USFDA in 2016.